Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00755313 · ClinicalTrials.gov registry record
Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer
A clinical trial of Breast Cancer and Fatigue, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 81
- Enrollment target
- 1
- Study location
NCT00755313 is a study of Breast Cancer and Fatigue that has completed, run by University of California, San Francisco. The registered enrollment target is 81 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00755313, a study of Breast Cancer and Fatigue, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 81 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Gathering information over time from laboratory tests, imaging scans, and assessment tests may help doctors learn more about the side effects of chemotherapy and plan the best treatment. PURPOSE: This clinical trial is studying the effects of chemotherapy on the brain in women with newly diagnosed early-stage breast cancer.
Conditions Studied
Interventions
- DRUG carboplatin
- DRUG cyclophosphamide
- DRUG docetaxel
- BIOLOGICAL trastuzumab
- DRUG aromatase inhibition therapy
Study Locations (1)
California
- UCSF Helen Diller Family Comprehensive Cancer Center - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2007-05 |
| Est. Completion | 2014-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00755313
The ClinicalTrials.gov registry entry for NCT00755313 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 81 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 7 conditions, with Breast Cancer appearing as the primary indexed condition, and to 5 interventions - of which carboplatin is the first listed.
NCT00755313 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00755313 about?
NCT00755313 is a clinical study titled "Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer". RATIONALE: Gathering information over time from laboratory tests, imaging scans, and assessment tests may help doctors learn more about the side effects of chemotherapy and plan the best treatment. PURPOSE: This clinical trial is studying the effects of chemotherapy on the brain in women with newly...
What is the current status of trial NCT00755313?
This trial is currently completed. The enrollment target is 81 participants. The study started on 2007-05. Estimated completion is 2014-06-06.
What conditions does trial NCT00755313 study?
This clinical trial studies the following conditions: Breast Cancer, Fatigue, Psychosocial Effects of Cancer and Its Treatment, Neurotoxicity, Cognitive/Functional Effects.
What interventions are being tested in trial NCT00755313?
The interventions under investigation include: carboplatin (DRUG), cyclophosphamide (DRUG), docetaxel (DRUG), trastuzumab (BIOLOGICAL), aromatase inhibition therapy (DRUG).
Who is sponsoring clinical trial NCT00755313?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00755313 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.